Amedisys, Inc. (AMED) Thwomps Q2 Profit Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Amedisys (AMED) Moves to Highs of Session Following Better-than-Expected Results
July 30, 2014 12:22 PM EDTAmedisys (NASDAQ: AMED) is gaining momentum amid today's stronger-than-expected Q2 results. Shares are now up 17% on heavy volume.
Amedisys, Inc. (NASDAQ: AMED) reported Q2 EPS of $0.25, $0.21 better than the analyst estimate of $0.04. Revenue for the quarter came in at $305... More
